Transmedics Group Inc (NASDAQ: TMDX) on Tuesday, plunged -0.82% from the previous trading day, before settling in for the closing price of $57.20. Within the past 52 weeks, TMDX’s price has moved between $56.03 and $177.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 98.50%. The company achieved an average annual earnings per share of 227.30%. With a float of $32.43 million, this company’s outstanding shares have now reached $33.56 million.
The extent of productivity of a business whose workforce counts for 584 workers is very important to gauge. In terms of profitability, gross margin is 59.29%, operating margin of 7.84%, and the pretax margin is 8.14%.
Transmedics Group Inc (TMDX) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Transmedics Group Inc is 3.39%, while institutional ownership is 109.82%. The most recent insider transaction that took place on Jan 07 ’25, was worth 86,694. In this transaction Chief Commercial Officer of this company sold 1,083 shares at a rate of $80.05, taking the stock ownership to the 20,843 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Commercial Officer sold 1,084 for $86.40, making the entire transaction worth $93,658. This insider now owns 20,843 shares in total.
Transmedics Group Inc (TMDX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 227.30% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Transmedics Group Inc (TMDX) is currently performing well based on its current performance indicators. A quick ratio of 7.33 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.93, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 1.47 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
The latest stats from [Transmedics Group Inc, TMDX] show that its last 5-days average volume of 2.47 million was inferior to 3.62 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 5.07%. Additionally, its Average True Range was 5.10.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 1.42%, which indicates a significant decrease from 6.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.02% in the past 14 days, which was lower than the 85.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.08, while its 200-day Moving Average is $119.72. Now, the first resistance to watch is $58.31. This is followed by the second major resistance level at $59.88. The third major resistance level sits at $61.54. If the price goes on to break the first support level at $55.08, it is likely to go to the next support level at $53.42. The third support level lies at $51.85 if the price breaches the second support level.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
Market capitalization of the company is 1.90 billion based on 33,562K outstanding shares. Right now, sales total 241,620 K and income totals -25,030 K. The company made 108,760 K in profit during its latest quarter, and 4,220 K in sales during its previous quarter.
